Timber Pharmaceuticals Analyst Ratings
Timber Pharmaceuticals Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/28/2023 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 04/10/2023 | 263.04% | HC Wainwright & Co. | $1 → $11 | Reiterates | → Buy |
| 10/26/2022 | -67% | HC Wainwright & Co. | $1.5 → $1 | Maintains | Buy |
| 08/29/2022 | -67% | HC Wainwright & Co. | $1.5 → $1 | Maintains | Buy |
| 05/02/2022 | -50.5% | HC Wainwright & Co. | $2 → $1.5 | Maintains | Buy |
| 03/31/2022 | -33.99% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/28/2023 | — | HC Wainwright & Co. | 降级 | 买入 → 中性 | |
| 2023 年 10 月 4 日 | 263.04% | HC Wainwright & Co. | $1 → 11 美元 | 重申 | → 购买 |
| 2022 年 10 月 26 日 | -67% | HC Wainwright & Co. | 1.5 美元 → 1 美元 | 维护 | 购买 |
| 08/29/2022 | -67% | HC Wainwright & Co. | 1.5 美元 → 1 美元 | 维护 | 购买 |
| 05/02/2022 | -50.5% | HC Wainwright & Co. | $2 → 1.5 美元 | 维护 | 购买 |
| 03/31/2022 | -33.99% | HC Wainwright & Co. | → 2 美元 | 启动覆盖开启 | → 购买 |
What is the target price for Timber Pharmaceuticals (TMBR)?
Timber Pharmicals（TMBR）的目标价格是多少？
The latest price target for Timber Pharmaceuticals (AMEX: TMBR) was reported by HC Wainwright & Co. on August 28, 2023. The analyst firm set a price target for $0.00 expecting TMBR to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月28日公布了Timber Pharmicals（美国证券交易所股票代码：TMBR）的最新目标股价。该分析公司将目标股价定为0.00美元，预计TMBR将在12个月内跌至-100.00％（可能下跌-100.00％）。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Timber Pharmaceuticals (TMBR)?
Timber Pharmicals（TMBR）的最新分析师评级是多少？
The latest analyst rating for Timber Pharmaceuticals (AMEX: TMBR) was provided by HC Wainwright & Co., and Timber Pharmaceuticals downgraded their neutral rating.
Timber Pharmicals（美国证券交易所股票代码：TMBR）的最新分析师评级由HC Wainwright & Co. 提供，Timber Pharmicals下调了中性评级。
When is the next analyst rating going to be posted or updated for Timber Pharmaceuticals (TMBR)?
Timber Pharmicals（TMBR）的下一次分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Timber Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Timber Pharmaceuticals was filed on August 28, 2023 so you should expect the next rating to be made available sometime around August 28, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与Timber Pharmicals的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Timber Pharmicals的最后一次评级是在2023年8月28日提交的，因此你应该预计下一个评级将在2024年8月28日左右公布。
Is the Analyst Rating Timber Pharmaceuticals (TMBR) correct?
Timber Pharmicals（TMBR）的分析师评级是否正确？
While ratings are subjective and will change, the latest Timber Pharmaceuticals (TMBR) rating was a downgraded with a price target of $0.00 to $0.00. The current price Timber Pharmaceuticals (TMBR) is trading at is $3.03, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Timber Pharmicals（TMBR）评级被下调，目标股价为0.00美元至0.00美元。Timber Pharmicals（TMBR）目前的交易价格为3.03美元，超出了分析师的预测区间。